Alerta De Seguridad para LifeCare PCA Infusion System

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Hospira.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2012-09-11
  • Fecha de publicación del evento
    2012-09-11
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: hospira lifecare pca infusion system the medicines and healthcare products regulatory agency (mhra), united kingdom posted a field safety notice concerning lifecare pca infusion system, manufactured by hospira, inc. the manufacturer has received customer reports related to improper use of the slide clamp when the syringe (vial) is manipulated, or when stopping the infusion during delivery of medication. failure to close the slide clamp whilst manipulating the syringe (vial) or stopping the infusion, may result in an over delivery of the medication being infused which has the potential to cause a life threatening/critical injury to the patient. furthermore, the manufacturer advised users to follow the labelled instructions for the correct use of the slide clamp when manipulating the syringe (vial) or when stopping infusion during delivery of fluids. hospira is in the process of creating cautionary labels for the pca device, which will alert clinicians to close the slide clamp prior to handling the pca vial and to open the slide clamp before starting therapy. the manufacturer is also investigating whether a design improvement is feasible to further mitigate this risk. for details, please refer to the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/ safetywarningsalertsandrecalls/fieldsafetynotices/con184398 if you are in possession of the product, please contact your supplier for necessary actions. posted on 11 september 2012.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Hospira LifeCare PCA Infusion System
  • Manufacturer

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Source
    DH